Stock code: 688363 Stock abbreviation: Bloomage Biotech Announcement No.: 2025-008

Bloomage Biotechnology Co., Ltd

Announcement of the 2024 annual profit distribution plan

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or material omissions in the content of this announcement, and assume legal responsibility for the authenticity, accuracy and completeness of its content.

Important Content Notes:

Distribution ratio per share: cash dividend of 0.11 yuan per share (tax included), no capital reserve conversion increase

share capital, and no bonus shares will be distributed

The profit distribution is based on the total share capital registered on the record date of the implementation of equity distribution, deducting the company's repurchase

The number of shares in the special securities account is the base, and the specific date will be specified in the announcement of the implementation of equity distribution.

If the company's total share capital is deducted from the company's special securities for repurchase before the equity record date for the implementation of equity distribution

If there is a change in the number of shares in the account, it is planned to maintain the distribution ratio per share unchanged and adjust the total distribution accordingly

forehead

The Company is not likely to be in breach of the Rules Governing the Listing of Stocks on the STAR Market of the Shanghai Stock Exchange (April 2024

Monthly Amendment) (hereinafter referred to as the "STAR Market Listing Rules") Article 12.9.1, Paragraph 1

Circumstances under item (8) that may be subject to other risk warnings.

1. The content of the profit distribution plan

(1) The specific content of the profit distribution plan

After the audit of Grant Thornton Certified Public Accountants (Special General Partnership), the company's 2024 consolidated financial statements were realized

Net profit attributable to shareholders of the parent company was 174,267,399.74 yuan, as of December 31, 2024, the company

The undistributed profit at the end of the interim statement of the parent company was 3,500,635,673.29 yuan. According to the resolution of the board of directors, the company intends to distribute profits in 2024 based on the total share capital registered on the record date of the implementation of equity distribution and the number of shares in the company's special securities account for repurchase. The profit distribution plan is as follows:

The company intends to distribute a cash dividend of 1.10 yuan (tax included) to all shareholders for every 10 shares. As of March 2025

On the 31st, the company's total share capital was 481,678,242 shares, the number of shares in the company's repurchase special securities account was 3,315,538 shares, and the number of shares entitled to participate in the profit distribution was 478,362,704 shares, which calculated a total cash dividend of 52,619,897.44 yuan (tax included). The total cash dividend of the company for the year was 52,619,897.44 yuan; During the year, the amount of share repurchase implemented by centralized bidding was RMB114,070,138.82 (excluding transaction costs such as stamp duty and transaction commissions), and the total amount of cash dividends and repurchases was RMB166,690,036.26, accounting for 95.65% of the net profit attributable to shareholders of the listed company for the year. Among them, the amount of repurchase and cancellation (hereinafter referred to as "repurchase and cancellation") with cash as consideration, the repurchase of shares by way of offer and centralized bidding (hereinafter referred to as "repurchase and cancellation") was 0 yuan, and the total amount of cash dividends and repurchase and cancellation was 52,619,897.44 yuan, accounting for 30.19% of the net profit attributable to shareholders of the listed company for the year.

The company holds 3,315,538 shares of the company through the repurchase special account and does not participate in this profit distribution.

If the total share capital of the company after deducting the number of shares in the special securities account for repurchase changes due to the conversion of convertible bonds into shares/repurchase of shares/share repurchase and cancellation of equity incentive grants/repurchase and cancellation of major asset restructuring shares during the period from the date of disclosure of this announcement to the registration date of the implementation of equity distribution, the company intends to maintain the distribution ratio per share unchanged and adjust the total distribution amount accordingly.

The profit distribution plan still needs to be submitted to the general meeting of shareholders for deliberation.

(2) Whether other risk warning situations may be triggered

The company has been listed for three full fiscal years, the net profit for the current year is positive and the undistributed profit at the end of the parent company's statement year is positive, and the company has no circumstances that may trigger other risk warnings as stipulated in Article 12.9.1, Paragraph 1 (8) of the Rules Governing the Listing of Stocks on the Science and Technology Innovation Board, and the relevant indicators are as follows:

Item Current Year Previous Year Previous Year

52,619,897.44 181,777,827.52 293,823,727.62

Total Cash Dividends (RMB)

(Estimated) (Number implemented) (Number implemented)

Total amount of repurchase and write-off (RMB) 0 0 0

Net profit attributable to shareholders of listed companies 174,267,399.74 592,555,911.37 970,918,593.78 (RMB)

The parent company's statements at the end of the year were undivided 3,500,635,673.29

Allocation Profit (RMB)

The accumulated cash distribution for the last three fiscal years was 528,221,452.58

Total Bonus (RMB)

Cumulative buyback Note 0 for the last three fiscal years

Total sales (RMB)

The average net profit for the last three fiscal years was 579,247,301.63

(RMB)(C)

The accumulated cash distribution for the last three fiscal years was 528,221,452.58

Total amount of bonuses and repurchase cancellations (RMB)

Accumulated cash points for the last three fiscal years

Bonus and total amount of repurchase write-offs (D) No

Less than $30 million

Cash dividend ratio (%)E=D/C 91.19

Whether the cash dividend ratio (E) is lower than No

30%

The cumulative R&D investment in the last three fiscal years was 1,300,784,523.26

Deposit amount (RMB)

The cumulative R&D investment in the last three fiscal years is:

Whether the deposit amount is more than 300 million yuan

Cumulative operating income for the last three fiscal years

Revenue (RMB) 17,805,886,083.87

The cumulative R&D investment in the last three fiscal years was 7.31

Proportion of revenue to cumulative operating income (%)

Cumulative R&D investment in the last three fiscal years

Percentage of revenue to accumulated operating income (H) No

Whether it is above 15%.

Whether it has touched the "Listing Rules for Stocks on the Science and Technology Innovation Board".

Article 12.9.1, paragraph 1 (viii) No

may be subject to other risks as set forth in this paragraph

Cautionary circumstances

2. The decision-making procedures performed by the company

(1) The convening, deliberation and voting of the board of directors meetings

The company held the 17th meeting of the second board of directors on April 9, 2025 to review and approve the profit share

This plan is in line with the profit distribution policy stipulated in the articles of association of the company.

(2) Opinions of the Board of Supervisors

On April 9, 2025, the company held the twelfth meeting of the second board of supervisors, and deliberated and approved the "Guan

Proposal for the company's 2024 profit distribution plan. The Board of Supervisors believes that the Company's 2024 annual profit distribution plan is formulated in accordance with the Articles of Association, with reference to the Self-Regulatory Guidelines for Listed Companies on the Science and Technology Innovation Board of the Shanghai Stock Exchange No. 1 - Standardized Operation, and after fully considering various factors such as the Company's profitability, cash flow status and capital needs, it is in line with the profit distribution policy in the Articles of Association, the review procedure is legal and compliant, and there is no harm to the interests of small and medium-sized shareholders. Approved the profit distribution plan and agreed to submit the plan to the Company's 2024 Annual General Meeting of Shareholders for consideration.

3. Relevant Risk Warning

(1) Analysis of the impact of cash dividends on earnings per share, cash flow, production and operation of listed companies

The profit distribution plan comprehensively considers the company's development stage, future capital needs and other factors, and will not have a significant impact on the company's operating cash flow, and will not affect the company's normal operation and long-term development.

(2) Other risk descriptions

The profit distribution plan still needs to be submitted to the company's 2024 annual general meeting of shareholders for review and approval, please pay attention to the investment risks.

The announcement is hereby made.

Board of Directors of Bloomage Biotechnology Co., Ltd

April 11, 2025